Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice

Behavioural Brain Research

Volumn 221, Issue 1, 2011, Pages 261-270

  Collombet, Jean Marc ^a,b   Béracochéa, Daniel ^c   Liscia, Pierrette ^a   Piérard, Christophe ^a   Lallement, Guy ^b   Filliat, Pierre ^b  

^a IRBA   (France)

^b CENTRE DE RECHERCHES   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Anxiety; Fear; Neuronal regeneration; Neuropathology; Soman; Spatial memory

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; NEURON SPECIFIC NUCLEAR PROTEIN; SOMAN;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONDITIONING; CONTROLLED STUDY; CONVALESCENCE; EMOTIONALITY; FEAR; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NERVE REGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 79954630127     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.006     Document Type: Article

References (46)

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004, 38:151-216.
2. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol 1983, 61:123-129.
3. McDonough J.H., Clark T.R., Slone T.W., Zoeffel D., Brown K., Kim S., et al. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology 1998, 19:381-391.
4. Brandeis R., Raveh L., Grunwald J., Cohen E., Ashani Y. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol Biochem Behav 1993, 46:889-896.
5. Filliat P., Baubichon D., Burckhart M.F., Pernot-Marino I., Foquin A., Masqueliez C., et al. Memory impairment after soman intoxication in rat: correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics. Neurotoxicology 1999, 20:535-549.
6. Filliat P., Coubard S., Pierard C., Liscia P., Beracochea D., Four E., et al. Long-term behavioral consequences of soman poisoning in mice. Neurotoxicology 2007, 28:508-519.
7. Raveh L., Brandeis R., Gilat E., Cohen G., Alkalay D., Rabinovitz I., et al. Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction. Toxicol Sci 2003, 75:108-116.
8. Raffaele K., Hughey D., Wenk G., Olton D., Modrow H., McDonough J. Long-term behavioral changes in rats following organophosphonate exposure. Pharmacol Biochem Behav 1987, 27:407-412.
9. Buccafusco J.J., Heithold D.L., Chon S.H. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine. Toxicol Lett 1990, 52:319-329.
10. Romano J.A., King J.M., Penetar D.M. A comparison of physostigmine and soman using taste aversion and nociception. Neurobehav Toxicol Teratol 1985, 7:243-249.
11. Myhrer T., Andersen J.M., Nguyen N.H., Aas P. Soman-induced convulsions in rats terminated with pharmacological agents after 45min: neuropathology and cognitive performance. Neurotoxicology 2005, 26:39-48.
12. Coubard S., Beracochea D., Collombet J.M., Philippin J.N., Krazem A., Liscia P., et al. Long-term consequences of soman poisoning in mice: part 2. Emotional behaviour. Behav Brain Res 2008, 191:95-103.
13. Mamczarz J., Pereira E.F., Aracava Y., Adler M., Albuquerque E.X. An acute exposure to a sub-lethal dose of soman triggers anxiety-related behavior in guinea pigs: interactions with acute restraint. Neurotoxicology 2010, 31:77-84.
14. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., Blanchet G. Medical management of organophosphate-induced seizures. J Physiol Paris 1998, 92:369-373.
15. Collombet J.M., Four E., Bernabe D., Masqueliez C., Burckhart M.F., Baille V., et al. Soman poisoning increases neural progenitor proliferation and induces long-term glial activation in mouse brain. Toxicology 2005, 208:319-334.
16. Collombet J.M., Carpentier P., Baille V., Four E., Bernabe D., Burckhart M.F., et al. Neuronal regeneration partially compensates the delayed neuronal cell death observed in the hippocampal CA1 field of soman-poisoned mice. Neurotoxicology 2006, 27:201-209.
17. Collombet J.M., Pierard C., Beracochea D., Coubard S., Burckhart M.F., Four E., et al. Long-term consequences of soman poisoning in mice. Part 1. Neuropathology and neuronal regeneration in the amygdale. Behav Brain Res 2008, 191:88-94.
18. John G.R., Lee S.C., Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003, 9:10-22.
19. Viviani B., Bartesaghi S., Corsini E., Galli C.L., Marinovich M. Cytokines role in neurodegenerative events. Toxicol Lett 2004, 149:85-89.
20. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.
21. Burns T.C., Verfaillie C.M., Low W.C. Stem cells for ischemic brain injury: a critical review. J Comp Neurol 2009, 515:125-144.
22. Leker R.R., Lasri V., Chernoguz D. Growth factors improve neurogenesis and outcome after focal cerebral ischemia. J Neural Transm 2009, 116:1397-1402.
23. Collombet J.M., Four E., Burckhart M.F., Masqueliez C., Bernabe D., Baubichon D., et al. Effect of cytokine treatment on the neurogenesis process in the brain of soman-poisoned mice. Toxicology 2005, 210:9-23.
24. Collombet J.M., Mourcin F., Grenier N., Four E., Masqueliez C., Baubichon D., et al. Effect of soman poisoning on populations of bone marrow and peripheral blood cells in mice. Neurotoxicology 2005, 26:89-98.
25. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego.
26. Lillie R.D., Fullmer H.M. Histopathologic technique and practice 1976, McGraw-Hill, New York, p. 208-9.
27. Beracochea D., Cagnard B., Celerier A., le Merrer J., Peres M., Pierard C. First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice. Neuroreport 2001, 12:375-378.
28. Pierard C., Liscia P., Valleau M., Drouet I., Chauveau F., Huart B., et al. Modafinil-induced modulation of working memory and plasma corticosterone in chronically-stressed mice. Pharmacol Biochem Behav 2006, 83:1-8.
29. Celerier A., Ognard R., Decorte L., Beracochea D. Deficits of spatial and non-spatial memory and of auditory fear conditioning following anterior thalamic lesions in mice: comparison with chronic alcohol consumption. Eur J Neurosci 2000, 12:2575-2584.
30. Celerier A., Pierard C., Beracochea D. Effects of ibotenic acid lesions of the dorsal hippocampus on contextual fear conditioning in mice: comparison with mammillary body lesions. Behav Brain Res 2004, 151:65-72.
31. Collombet J.M., Masqueliez C., Four E., Burckhart M.F., Bernabe D., Baubichon D., et al. Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus. Neurosci Lett 2006, 398:337-342.
32. Nakatomi H., Kuriu T., Okabe S., Yamamoto S., Hatano O., Kawahara N., et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002, 110:429-441.
33. Sun D., Bullock M.R., McGinn M.J., Zhou Z., Altememi N., Hagood S., et al. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp Neurol 2009, 216:56-65.
34. Paradiso B., Marconi P., Zucchini S., Berto E., Binaschi A., Bozac A., et al. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci USA 2009, 106:7191-7196.
35. Park J.H., Cho H., Kim H., Kim K. Repeated brief epileptic seizures by pentylenetetrazole cause neurodegeneration and promote neurogenesis in discrete brain regions of freely moving adult rats. Neuroscience 2006, 140:673-684.
36. Yan H.Q., Yu J., Kline A.E., Letart P., Jenkins L.W., Marion D.W., et al. Evaluation of combined fibroblast growth factor-2 and moderate hypothermia therapy in traumatically brain injured rats. Brain Res 2000, 887:134-143.
37. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 2004, 28:273-283.
38. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
39. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nat Rev Neurosci 2009, 10:423-433.
40. Barkus C., McHugh S.B., Sprengel R., Seeburg P.H., Rawlins J.N., Bannerman D.M. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol 2010, 626:49-56.
41. Morris R., Frey S., Kasambira T., Petrides M. Ibotenic acid lesions of the basolateral, but not the central, amygdala interfere with conditioned taste aversion: evidence from a combined behavioral and anatomical tract-tracing investigation. Behav Neurosci 1999, 113:291-302.
42. Koo J.W., Han J.S., Kim J.J. Selective neurotoxic lesions of basolateral and central nuclei of the amygdala produce differential effects on fear conditioning. J Neurosci 2004, 24:7654-7662.
43. Morgane P.J., Galler J.R., Mokler D.J. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 2005, 75:143-160.
44. Vertes R.P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006, 142:1-20.
45. Perez J.A., Clinton S.M., Turner C.A., Watson S.J., Akil H. A new role for FGF2 as an endogenous inhibitor of anxiety. J Neurosci 2009, 29:6379-6387.
46. Graham B.M., Richardson R. Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. Neuropsychopharmacology 2009, 34:1875-1882.